XLO — XILIO THERAPEUTICS INC

Ownership history in Squarepoint Ops LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in XILIO THERAPEUTICS INC (XLO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 328,794 +93,338 +39.6% 0.00% $277K $11.80
2025 Q2 INITIATED 235,456 — — 0.00% $160K $9.52
% of Fund (quarterly)    XLO price (monthly, adj. close)

Other funds also holding XLO

As of 2025 Q4 — sorted by position size

Bain Capital Life Sciences Investors, LLC 3Y 7Y 0.36% GILEAD SCIENCES, INC. 0.3% STEMPOINT CAPITAL LP 0.22% Sio Capital Management, LLC 3Y 7Y 0.21% Frazier Life Sciences Management, L.P. 3Y 0.1% Velan Capital Investment Management LP 3Y 0.06% Stonepine Capital Management, LLC 3Y 7Y 0.06% Ghisallo Capital Management LLC 3Y 0.03% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.01% Point72 Asset Management, L.P. 3Y 7Y 0.0%
← Back to Squarepoint Ops LLC Holdings